Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 4/20 | 0.43 |
| ▸ | CES1 | P23141 | 4/20 | 0.43 |
| ▸ | PARP1 | P09874 | 3/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.37 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.36 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28085635 | 1.00 | DGAT1 (0.45) | DGAT1CES2CES1PARP1ROCK2 | |
| SCHEMBL7813369 | 0.82 | HSD17B1 (0.44) | DGAT1CES2CES1 | |
| SCHEMBL4591061 | 0.82 | DGAT1 (0.42) | DGAT1CES2CES1PARP1ROCK2 | |
| SCHEMBL30995317 | 0.82 | DGAT1 (0.42) | DGAT1CES2CES1PARP1ROCK2 | |
| SCHEMBL9491069 | 0.82 | DGAT1 (0.42) | DGAT1CES2CES1PARP1ROCK2 | |
| SCHEMBL811079 | 0.82 | DGAT1 (0.42) | DGAT1CES2CES1PARP1ROCK2 | |
| Hydrochloric Acid SCHEMBL30995407 | 0.80 | DGAT1 (0.41) | DGAT1CES2CES1PARP1ROCK2 | |
| SCHEMBL25679030 | 0.80 | DGAT1 (0.50) | DGAT1CES2CES1PARP1ROCK2 | |
| SCHEMBL4514123 | 0.80 | DGAT1 (0.41) | DGAT1CES2CES1PARP1ROCK2 | |
| SCHEMBL8727078 | 0.80 | DGAT1 (0.41) | DGAT1CES2CES1PARP1ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4164891-A1 | FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS | Crime Science Technology (FR) | 2023-04-19 | — | — | EP | claimed |
| WO-2021250358-A1 | FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS | Crime Science Technology (FR) | 2021-12-16 | — | — | WO | claimed |
| CN-112375489-A | Screw and processing technology thereof | 乐清市徐泰螺钉厂 | 2021-02-19 | — | — | CN | claimed |
| CN-105399685-B | The alternatively preparation method and applications of the heteroaromatic compounds of property JAK3 and/or JAK1 kinase inhibitors | 深圳微芯生物科技有限责任公司 | 2018-05-22 | — | — | CN | claimed |
| CN-105732428-A | Tetrafluorobenzonitrile production method | 江苏维尤纳特精细化工有限公司 | 2016-07-06 | — | — | CN | claimed |
| EP-1631995-A2 | MANUFACTURE OF A POLYMER DEVICE | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2006-03-08 | — | — | EP | claimed |
| WO-2004100282-A2 | MANUFACTURE OF A POLYMER DEVICE | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2004-11-18 | — | — | WO | claimed |
| CN-119192103-A | Five-membered heterocyclic amide compound, preparation method and application thereof, and bactericide | 贵州大学 | 2024-12-27 | — | — | CN | disclosed |
| CN-117800827-A | Preparation method of medicine intermediate 2,3,4, 5-tetrafluorobenzoic acid | 盐城嘉昊辰科技有限公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-3980088-A1 | BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME | The Regents of the University of California (US) | 2022-04-13 | — | — | EP | disclosed |
| CN-112375489-A | Screw and processing technology thereof | 乐清市徐泰螺钉厂 | 2021-02-19 | — | — | CN | disclosed |
| CN-112375489-A | Screw and processing technology thereof | 乐清市徐泰螺钉厂 | 2021-02-19 | — | — | CN | disclosed |
| WO-2020247629-A1 | BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-12-10 | — | — | WO | disclosed |
| US-20070172978-A1 | Manufacture of a polymer device | CAMBRIDGE UNIVERSITY TECHNICAL SERVICE LIMITED (GB) | 2007-07-26 | — | — | US | disclosed |
| EP-1631995-A2 | MANUFACTURE OF A POLYMER DEVICE | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2006-03-08 | — | — | EP | disclosed |
| US-20060045953-A1 | Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers | SENOMYX, INC. | 2006-03-02 | — | — | US | disclosed |
| US-6967196-B1 | Sulfonamide compounds and uses thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-11-22 | — | — | US | disclosed |
| US-20050197350-A1 | Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof | TAISHO PHARMACEUTICAL CO., LTD. | 2005-09-08 | — | — | US | disclosed |
| WO-2004100282-A2 | MANUFACTURE OF A POLYMER DEVICE | CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) | 2004-11-18 | — | — | WO | disclosed |
| WO-1995016682-A1 | CYCLIC AMIDE DERIVATIVES AS NEUROKININ A ANTAGONISTS | ZENECA LIMITED (GB) | 1995-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197350-A1 | Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof | HCRTR2, MCHR1, MCHR2 | DGAT1 3394/4885CES2 953/4885CES1 2154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.